Privately owned Huvepharma® is a fast-growing global pharmaceutical and feed additives company with a focus on developing, manufacturing and marketing human and animal health products.
Huvepharma®’s fermentation capabilities of 70 years evolved into a state-of-the art, high-capacity manufacturing platform with all downstream processing and related functions operated internally to allow autonomy to manufacture finished product forms from strain to shelf. Recently, the company has installed a number of renewable energy installations in Bulgaria to support our commitment to carbon-neutral manufacturing by 2030.
Huvepharma employs highly skilled individuals with extensive experience in the animal health industry, is customer and market centric and driven by an entrepreneurial approach to business. The company achieved an exceptional revenue growth during the past 20 years and recorded a turnover of EUR 715 million in 2022.